Celyad Oncology SA (CLYYF)
0.15
0.00 (0.00%)
USD |
OTCM |
Feb 13, 16:00
Celyad Oncology Enterprise Value : -23.53M for Feb. 13, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Galapagos NV | -1.340B |
| UCB SA | -- |
| Ion Beam Applications SA | -- |
| Fagron NV | -- |
| AgomAb Therapeutics NV | -- |
Enterprise Value Related Metrics
| Earnings Yield | -113.0% |
| Normalized Earnings Yield | -113.87 |